About AngioScore
AngioScore is a company based in Fremont (United States) founded in 2003 was acquired by Spectranetics GSM in May 2014. AngioScore has raised $87 million across 4 funding rounds from investors including Spectranetics GSM, Saints Capital and Psilos Group. AngioScore operates in a competitive market with competitors including Contego Medical, Echopoint Medical, Limflow, Vascular Solutions and ev3 Endovascular, among others.
- Headquarter Fremont, United States
- SectorsHealthcare
- Website angioscore.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Spectranetics GSM (May 2014)
- Legal Name Angioscore Inc
- Total Equity Funding$87M (USD)
in 4 rounds
- Latest Funding Round$12M (USD), Series E
Apr 2011
- InvestorsSpectranetics GSM
& 6 more
- Acquired bySpectranetics GSM
(May 2014)
Apps and channels of AngioScore
its YouTube channel Signify has 1.44K subscribers and 30 videos.
Videos from AngioScore
The most watched videos on AngioScore's YouTube channel, Signify (1.44K subscribers). Click a video to play it here.
More on Signify.
Funding Insights of AngioScore
AngioScore has successfully raised a total of $87M across 4 strategic funding rounds. The most recent funding activity was a Series E round of $12 million completed in April 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $87M
- Total Rounds 4
- Last Round Series E — $12M
- First Round $15M
(Aug 2004)
- Investors Count 6
All 4 funding rounds of AngioScore with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2011 | $12M | Series E | – | Saints Capital | |
| Oct 2007 | $30M | Series E | – | – | |
| Apr 2006 | $30M | Series D | – | – | |
| Aug 2004 | $15M | Series B | – | – |
7 investors in total: 7 institutional.
Investors in AngioScore
AngioScore has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Spectranetics GSM, Saints Capital and Psilos Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Direct secondary investments are made in private company shares. | – | saintscapital.com | Denver, United States | |
Growth-stage investments focused on US tech and life sciences. | – | psilos.com | New York, United States | |
Venture capital firm focused on life science, medical device and healthcare companies | – | thpartners.net | San Francisco, United States | |
Expansion stage tech-focused VC firm investing primarily in the US | – | questm.com | Baltimore, United States | |
US focused early-stage VC firm | – | pelionvp.com | Salt Lake City, United States | |
- | – | ctventures.com | - | |
Disposable fibreoptic catheters for minimally invasive cardiovascular procedures | 1984 | spectranetics.com | Colorado Springs, United States |
Investor details for AngioScore
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AngioScore
8 people are tracked at AngioScore (7 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Scott Drake | Director | Board & advisors |
B. Kristine Johnson | Director | Board & advisors |
Todd Schermerhorn | Director | Board & advisors |
William C. Jennings | Director | Board & advisors |
Daniel Pelak | Director | Board & advisors |
Joseph M. Ruggio | Director | Board & advisors |
Maria Sainz | Director | Board & advisors |
R. John Fletcher | Chairman of the Board | Team |
Complete people profiles for AngioScore
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AngioScore
4 dated milestones of AngioScore across 11 years, from founding to its latest funding, stage changes and deals.
- Founded AngioScore is founded.
- Funding First funding round of $15.0M.
- Funding Latest funding round, Series E, of $12.0M.
- Exit Acquired by Spectranetics GSM.
Competitors of AngioScore
AngioScore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Contego Medical, Echopoint Medical, Limflow, Vascular Solutions and ev3 Endovascular, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| contegomedical.com | 2005 | Raleigh, United States | $66.01M | – | Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature | |
| echopointmedical.com | 2018 | London, United Kingdom | $9.74M | 8 | Smart devices for monitoring coronary artery disease are developed. | |
| limflow.com | 2012 | Paris, France | $97.45M | – | Developer a system for venous arterialization of the lower limbs | |
| vasc.com | 1997 | Minneapolis, United States | $12M | 562 | Products for vascular diagnostics and interventional procedures are developed. | |
| ev3.net | 2000 | Plymouth, United States | $58.8M | 1,307 | Surgical products for treatment of Peripheral vascular & Neurovascular diseases | |
| csi360.com | 1989 | Saint Paul, United States | $121.34M | 780 | Devices for treating peripheral and coronary vascular disease are developed. | |
| terumo.com | 1921 | Somerset, United States | – | – | Portfolio of medical devices for interventional cardiology is provided. | |
| shapemem.com | 2009 | Santa Clara, United States | $77.27M | 37 | Embolization devices are developed using Shape Memory Polymer foams. | |
| spectranetics.com | 1984 | Colorado Springs, United States | – | – | Disposable fibreoptic catheters for minimally invasive cardiovascular procedures |
Detailed competitors of AngioScore
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AngioScore
Websites that share an audience with AngioScore (angioscore.com).
Websites whose visitors overlap most with AngioScore. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| angiodynamics.com | 21% | 18K | #1,595,457 | View details |
Latest news on Angioscore
Complete news archive for AngioScore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to AngioScore
10 companies that operate in the same segment as AngioScore (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AngioScore
AngioScore was founded in 2003 and raised its 1st funding round 1 year after it was founded.
AngioScore is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
AngioScore is a funded company, having raised a total of $87M across 4 funding rounds to date. The company's 1st funding round was a Series B of $15M, raised on Aug 2004.
AngioScore was founded in 2003 as an Israeli-American startup focused on medical devices for cardiovascular treatments. The AngioSculpt Scoring Balloon Catheter was created to address coronary and peripheral artery diseases through angioplasty procedures. Regulatory approvals, including CE marking and FDA clearance, were secured for these products. The company was acquired by Spectranetics in June 2014, with operations centered in Fremont, United States.
AngioScore's top competitors include Contego Medical, Limflow and Shape Memory Medical.
AngioScore has 7 investors. Key investors include Spectranetics GSM, Saints Capital, Psilos Group, Telegraph Hill Partners, and QuestMark Partners.
AngioScore operates through Angioscore Inc.
Yes. AngioScore was acquired by Spectranetics GSM in May 2014.